Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Prokidney (PROK) Net Income towards Common Stockholders: 2020-2024

Historic Net Income towards Common Stockholders for Prokidney (PROK) over the last 5 years, with Dec 2024 value amounting to -$61.2 million.

  • Prokidney's Net Income towards Common Stockholders rose 12.69% to -$35.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$159.2 million, marking a year-over-year decrease of 16.60%. This contributed to the annual value of -$61.2 million for FY2024, which is 72.51% down from last year.
  • According to the latest figures from FY2024, Prokidney's Net Income towards Common Stockholders is -$61.2 million, which was down 72.51% from -$35.5 million recorded in FY2023.
  • In the past 5 years, Prokidney's Net Income towards Common Stockholders ranged from a high of -$26.7 million in FY2020 and a low of -$148.1 million during FY2022.
  • Its 3-year average for Net Income towards Common Stockholders is -$81.6 million, with a median of -$61.2 million in 2024.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first crashed by 168.62% in 2022, then skyrocketed by 76.06% in 2023.
  • Over the past 5 years, Prokidney's Net Income towards Common Stockholders (Yearly) stood at -$26.7 million in 2020, then tumbled by 106.16% to -$55.1 million in 2021, then slumped by 168.62% to -$148.1 million in 2022, then spiked by 76.06% to -$35.5 million in 2023, then crashed by 72.51% to -$61.2 million in 2024.